Patients who develop psychosis or agitated behavior secondary to neurological disorders present a therapeutic dilemma. The authors review clinical efficacy and side effect profiles of clozapine in a cohort of 16 patients with various neurobehavioral disorders. One-third showed a marked decrease in symptoms while on clozapine. However, one- quarter developed an acute confusional state; of these, all had diffuse slowing on their baseline EEG prior to starting the drug.
J Neuropsychiatry Clin Neurosci 1996; 8:92-96